DI BELLA METHOD
>
DOCUMENTATION INDEX > MDB - Documents
Different response to the long-acting somatostatin analogues lanreotide and octreotide in a patient with a malignant carcinoid.
(30/05/2003)
Detail
Distribution of somatostatin receptors in normal and neoplastic human tissues: recent advances and potential relevance.
(30/05/2003)
Detail
Distribution and functional significance of somatostatin receptors in malignant melanoma.
(30/05/2003)
Detail
Comparison of somatostatin analog and meta-iodobenzylguanidine radionuclides in the diagnosis and localization of advanced neuroendocrine tumors.
(30/05/2003)
Detail
Control of tumor size and disease activity during cotreatment with octreotide and the growth hormone receptor antagonist pegvisomant in an acromegalic patient.
(30/05/2003)
Detail
Comparison of In-111 octreotide and Tc-99m (V) DMSA scintigraphy in the detection of medullary thyroid tumor foci in patients with elevated levels of tumor markers after surgery.
(30/05/2003)
Detail
Somatostatinergic control of Kaposi's sarcoma growth through the inhibition of angiogenesis]
(30/05/2003)
Detail
Chromogranin A plasma concentration and expression in pancreatic islet cell tumors of dogs and cats.
(30/05/2003)
Detail
Comparison of four 64Cu-labeled somatostatin analogues in vitro and in a tumor-bearing rat model: evaluation of new derivatives for positron emission tomography imaging and targeted radiotherapy.
(30/05/2003)
Detail
Dosimetric comparison of radionuclides for therapy of somatostatin receptor-expressing tumors.
(30/05/2003)
Detail
Clinical correlates in acromegalic patients with pituitary tumors expressing GSP oncogenes.
(30/05/2003)
Detail
NADPH-diaphorase colocalization with somatostatin receptor subtypes sst2A and sst2B in the retina.
(30/05/2003)
Detail
Coexistence of somatostatin receptor subtypes in the human neuroblastoma cell line LA-N-2.
(30/05/2003)
Detail
Involvement of MAP kinase and c-fos signaling in the inhibition of cell growth by somatostatin.
(30/05/2003)
Detail
Combined somatostatin analog and follicle-stimulating hormone for women with polycystic ovary syndrome resistant to conventional treatment.
(30/05/2003)
Detail